Matthew Shawn Morris Sells 53,722 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 53,722 shares of the stock in a transaction on Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at $1,857,441.12. This represents a 44.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Thursday, July 2nd, Matthew Shawn Morris sold 59,037 shares of Privia Health Group stock. The stock was sold at an average price of $27.33, for a total transaction of $1,613,481.21.
• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total value of $1,601,159.96.
• On Friday, June 26th, Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total value of $2,231,826.30.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The shares were sold at an average price of $24.99, for a total transaction of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The stock was sold at an average price of $24.96, for a total transaction of $25,384.32.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $27.21 on Thursday. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of 170.07, a PEG ratio of 2.15 and a beta of 0.83. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $27.70. The stock’s 50 day moving average price is $23.65 and its 200 day moving average price is $23.08.

Analysts Set New Price Targets

PRVA has been the subject of several research reports. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Evercore set a $26.00 price target on shares of Privia Health Group in a report on Wednesday, April 8th. Canaccord Genuity Group reduced their price objective on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Finally, Barclays dropped their target price on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Institutional Investors Weigh In On Privia Health Group

A number of large investors have recently made changes to their positions in the company. Bayban acquired a new position in Privia Health Group in the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. raised its stake in Privia Health Group by 456.2% during the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after purchasing an additional 926 shares during the period. Global Retirement Partners LLC lifted its holdings in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after purchasing an additional 1,351 shares in the last quarter. Harbor Investment Advisory LLC purchased a new stake in shares of Privia Health Group in the second quarter valued at $69,000. Finally, Canada Pension Plan Investment Board boosted its position in shares of Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.